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Abstract 
Nucleic acids-based therapies have recently developed as next-generation 
agents for treating and preventing viral infection, cancer, and genetic disor-
ders, but their use is still limited due to its relatively poor delivery into tar-
geted cells. We designed and synthesized new amphiphilic amino acid deriva-
tives (cysteine-based) of low molecular weight, formed by the same pentapep-
tide (AG2: WWCOO) N-acylated, with different hydrophobic chains con-
taining from 12 to 18 carbons, named AG2-Cn (N), which dimerize by oxida-
tion in the presence of pLenti-CMV-GFP Puro plasmid (P) in the respective 
gemini. We determined transfection efficiency, critical micelle concentration, 
particle size, ζ-potential and cytotoxicity for the derivatives obtained. We 
found that all the synthesized compounds were active for DNA delivery and 
had greater ability to transfect CHO-K1 cells. In particular, AG2-C18 is a 
promising carrier for gene delivery because it showed no cytotoxicity and its 
activity was greater than or equal to the commercial actives currently used. 
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1. Introduction 
Gene therapy is a promising approach, with a potential to improve human 
health [1]. A successful gene therapy depends on efficient, safe and stable gene 
delivery systems. Chemically mediated non-viral vectors, such as cationic lipids, 
exhibit low immunogenicity, compared to viral vectors [2] [3]. Amphiphilic 
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gemini, a specific group of cationic lipids, has shown efficient transfection activ-
ity [4] [5]. These are dimeric amphiphiles with two hydrophilic heads and two 
hydrophobic groups per molecule, separated by a covalently bound spacer chain 
at the head groups, and are primarily used in material sciences because of their 
characteristic low surface tension [6] [7] [8] [9]. In recent years, there has been 
extensive research on gemini amphiphiles as non-viral gene delivery carriers for 
both in vitro and in vivo applications. These agents have a versatile chemical 
structure, can be easily produced on a laboratory scale, can compact DNA to 
nano-sized lipoplexes and show relatively low toxicity, compared to monomeric 
surfactants [4]. The transfection activity of gemini is influenced by the chemical 
nature of the head groups, length and saturation of the hydrophobic chains and by 
the chemical composition and length of the spacer [10] [11] [12].  
Several classes of natural amino acid-based gemini have been synthesized and 
characterized for the purpose of gene delivery [13] [14] [15] [16]. One of the 
methods most commonly used for the synthesis of amphiphilic amino acid de-
rivatives is the peptide N-terminal acylation [16]. If the peptide has cysteine in 
its sequence, it may dimerize by oxidative coupling obtaining the corresponding 
gemini [17] [18] [19] [20]. 
We recently described a new gemini 3b derived from a tetrapeptide consisting 
of tryptophan and ornithine (COCH3-WWOO-CONH2), designed with struc- 
tural requirements similar to those for AMPs (antimicrobial peptides) and CPPs 
(cell penetrating peptides) [21]. This gemini is active towards bacteria causing 
foodborne diseases and has a potential longer biological half-life, as ornithine 
gives gemini enzymatic resistance. Structure activity relationship studies (SARS) 
determined that gemini 3b shows greater activity when the sequence has tryp-
tophan residues and the ornithine residues are adjacent [22] [23].  
The current study presents the development of new amphiphilic carriers with 
simple structure (molecular mass < 1 KDa), aimed to achieve high DNA in vitro 
transfection efficiency. We describe the synthesis of a series of new N-acyl and 
cysteine-based amphiphilic amino acid derivatives named AG2-Cn(N) (Table 1 
and Figure 1), where the head group derives from the sequence of the gemini 3b 
(WWCOO) and the tail group, acylated to the N-terminus of peptide, has been 
systematically varied.  
 
Table 1. Sequences, characterization and CMC of the synthetic monomeric amphiphiles. 
Identification Sequence Molecular  massa (Da) 
Net  
Chargeb 
RT by 
RP-HPLCc 
CMC 
(µM)d 
AG2-C12 CH3-(CH2)10-CO-WWCOO-CONH2 902.574 903.3 +2 22.049 54,5 
AG2-C14 CH3-(CH2)12-CO-WWCOO-CONH2 930.605 931.1 +2 22.071 18,54 
AG2-C16 CH3-(CH2)14-CO-WWCOO-CONH2 930.605 936.5 +2 22.085 64,2 
AG2-C18 CH3-(CH2)16-CO-WWCOO-CONH2 986.668 985,6 +2 22.093 21,6 
aCalculated (left) and determined by ESI-MS (right). bCalculated at pH 7.4. cA C4 column was used, and 
peptides were eluted using a gradient elution of 5% - 95% of ACN in water containing 0.1% TFA. dDeter-
mined in Hepes 15 mMpH 7.4, DTT 10 mM. 
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Figure 1. Structure of the synthetic monomeric amphiphiles. 
 
The design of the structure of these compounds is potentially better than that 
of gemini 3b for two reasons, firstly the technique used in the hydrophobization 
of the peptide sequence has greater efficiency and yield and, secondly, the pres-
ence of the cysteine residue, gives AG2-Cn better interfacial properties and 
therefore greater biological activity. 
AG2-Cn(monomer) dimerizes by oxidation in the presence of pLenti-CMV- 
GFP Puroplasmid (P) in the respective gemini during the formation of the lipo-
plex. 
For the derivatives obtained, we determined critical micelle concentration 
(CMC), particle size, ζ-potential, cytotoxicity, antimicrobial activity, and gene 
transfection efficiency for HEK293 T and CHO-K1 cells using pEGFP as re-
porter gen. 
2. Materials and Methods 
2.1. Synthesis and Characterization of Monomeric Amphiphiles 
Firstly, AG2 peptide (NH2-WWCOO-CONH2) was synthesized using Fmoc- 
solid phase peptide synthesis method [24]. Secondly, the lipophilic acid (lauric, 
myristic, palmitic and oleic) was attached to the N-terminus of a resin-bound 
peptide using the same synthesis method as for AG2 to obtain AG2-C12; AG2- 
C14; AG2-C16 and AG2-C18, respectively (Table 1). Rink amide 4-Methylbenzy- 
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drylamine resin (MBHA) was used to prepare the C-terminal peptide amide. 
Couplings were performed by PyBOP ((Benzotriazol-1-yloxy)tripyrrolidi-no- 
phosphonium hexafluorophosphate) and NMM (4-methylmorpholine) was used 
as catalyst; Fmoc-deblockings were done with 20% piperidine in DMF (Di-
methylformamide) (v/v). The final cleavage from the resin was achieved by a 
mixture of TFA (trifluoracetic acid) /H2O/EDT (Ethanedithiol)/TIS (Triisopro-
pylsilane) (94.5: 2.5: 2.5: 0.5) (v/v). After 3 h, the resin was filtered off and the 
crude peptide was precipitated in dry cold diethyl ether, centrifuged and washed 
several times with cold diethyl ether until scavengers were removed. The product 
was then dissolved in water and lyophilized twice.  
The amphiphiles were analyzed by analytical RP-HPLC (Reverse Phase High 
Pressure Liquid Chromatography) using a Jupiter (Phenomenex, Torrence, CA, 
USA) C4 column (5 µm, 300 Å, 150 × 4.60 mm). The amphiphiles were eluted 
with a linear gradient of 5% - 95% acetonitrile with 0.1% TFA at flow rate of 0.8 
mL per min for 33 min at 30˚C. The parameters corresponding to the chroma-
tographic analysis were those obtained after an optimization process. The broad 
gradient range of acetonitrile (5% - 95%) was applied to detect the presence of 
impurities of different degrees of hydrophobicity. The application of higher 
temperature to room temperature is to facilitate the elution of hydrophobic 
compounds of interest and to take care of the useful half life of the column used. 
The absorbance was measured at 220 and 240 nm. All the amphiphiles syntheti-
cally prepared were analyzed by ESI-MS (electrospray ionization mass spec-
trometry)using UPLC-MS SQD 2 (Waters) and the peptide amino acid sequence 
was confirmed by automatic Edman Degradation, performed on a Shimadzu 
PPSQ-23-A sequencer. 
2.2. Determination of Critical Micellar Concentration  
Critical micellar concentrations of monomeric amphiphiles were obtained by 
measuring surface tension using a CSC Scientific Du Nouytensiometer. Serial 
dilutions were prepared from a concentrated stock solution of the amphiphiles 
in Hepes buffer (10 mM, pH 7.4) containing DTT (Dithiothreitol) (15 mM) to 
avoid detergent oxidation. A plot of the tension (mN/m) fluorescence versus the 
logarithm of the surfactant concentration displayed a sharp break and the cor-
responding concentration was considered to be the CMC.  
2.3. Preparation and Characterization of Complexes 
The plasmid pLenti CMV GFP Puro (658-5) was a gift from Eric Campeau (Ad-
dgene plasmid # 17448) [25]. Lipoplexes were prepared according to the tech-
nique described by Wang et al. [26]. DNA complexes at N/P ratios of 1.2, 2.4, 
4.8, 9.6, 15.0, 19.2, 28.0, and 38.4 were prepared by adding AG2-Cn from a 5 mM 
methanol stock solution to a 20 µg pLenti-CMV-GFP Puro (Addgen plasmid 
DNA into 1 mL Hepes buffer (15 mM, pH 7.4) under constant stirring. The 
mixture was incubated for 30 minutes at room temperature. DNA concentration 
was checked by measuring its absorbance at 260 nm. Complexes were kept at 
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room temperature to allow cross-linking to occur prior to further characteriza-
tion. The particle size and ζ-potential of the complexes were further determined 
by dynamic light scattering using a ZetaSizer Nano ZS90 (Malvern, Worcester-
shire, U.K) with the following specifications: refractive index, 1.45 (typical lipo-
some RI); medium viscosity, 1.054 cP; medium dielectric constant, 80; scattering 
angle, 90°; temperature, 25˚C. Data were analyzed using the multimodal number 
distribution software included in the instrument. ζ-potentials were measured 
according to the following specifications: refractive index, 1.45 (typical liposome 
RI); medium viscosity, 1.054 cP; medium dielectric constant, 80; scattering an-
gle, 90˚; temperature, 25˚C. 
2.4. Agarose Gel Electrophoresis  
The ability of the amphiphiles to condense the DNA was determined by agarose 
gel electrophoresis. The AG-2-Cn/pLenti-CMV-GFP Puro plasmid complex was 
prepared at N/P ratios ranging from 0.6 to 9.6. After 30-minute incubation, the 
complex was electrophoresed at 100 V for 15 minutes on agarose gels (1.0%, 
w/v).The location of plasmid bands was visualized under ultraviolet light by 
Gelred™ fluorescent dye. 
2.5. Gene Transfection Assay 
Gene transfection efficiency of AG2-Cn/pLenti-CMV-GFP Puro plasmid com-
plex was evaluated in HEK293 T and CHO-K1 cells, using GFP (green fluores-
cent protein) as reporter gene. Briefly, HEK293 T and CHO-K1 cells were seeded 
into 24-well plates at a density of 3 × 105 cells per well, respectively. After 24 h of 
incubation, the culture medium was removed. Cells were added with fresh cul-
ture medium containing AG2-Cn/pLenti-CMV-GFP Puro complexes, with dif-
ferent N/P ratios, at 37˚C, and incubated for another 3 h. The culture medium 
was then replaced and the cell culture was expanded. After additional 21 h incu-
bation, GFP expression in the transfected cells was observed by fluorescent mi-
croscopy and quantitated by flow cytometry. Commercial transfection reagents: 
Lipofectamine 2000 and PEI (Polyethylenimine) were used as controls. The ex-
periment was repeated three times. 
2.6. Detection of Antimicrobial Activity  
The agar-well-diffusion assay was used to investigate antimicrobial activity of 
amphiphiles [27]. For this purpose, 1 mL overnight culture of each indicator 
strain was added to 19 mL of molten Nutrient Agar Mueller Hinton (Difco) and 
poured into a sterile Petri dish. After cooling, wells of 5 mm diameter were cut 
out in the agar plates and filled with 50 µL of amphiphile aqueous solution, at 
two concentrations, one below and one above CMC. The plates were incubated 
at 37˚C for 24 h and the diameters of the clear inhibition zones were subse-
quently measured. Each assay was repeated three times and the results were ex-
pressed as an average of the values obtained. The following bacterial strains from 
ATCC (American Type Culture Collection) were used as indicators of lipopep-
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tideantimicrobial activity: Listeria monocytogenes ATCC 15313; Bacillus subtilis 
ATCC 6633; Staphylococcus aureus ATCC 25923; Escherichia coli ATCC 25922 
and Pseudomonas aeruginosa ATCC 27857.  
2.7. Hemolytic Assay 
For the determination of hemolytic activity, Triton X-100 (1%, w/v), free AG2- 
Cn, and AG-2-Cn/pLenti-CMV-GFP Puro plasmid complexes were dissolved in 
PBS (phosphate buffered saline) with pH adjusted to 7.4. Serial dilutions were 
performed for amphiphile-containing solutions to obtain concentrations ranging 
from 1000 µg/mL to 0.5 µg/mL. Aliquots (200 μL) for each sample were trans-
ferred into 0.6 mL microcentrifuge tubes. RBCs (Rat red blood cells) were sus-
pended in PBS (0.4 % v/v) at pH 7.4, and 200 μL of RBCs solution was mixed 
with the sample solution and incubated at 37˚C for 1 h. The mixture was then 
centrifuged at 1500 rpm for 10 min. 100 μL of supernatant was collected from 
each sample, and the absorbance was measured at 540 nm using a microplate 
reader to determine the hemoglobin concentration released. The relative hemo-
lytic capacity was calculated by normalizing the absorbance of samples to that 
treated with Triton X-100 [28].  
2.8. Compound Toxicity Assay by Crystal Violet Dye 
The toxicity of each free amphiphile was determined by crystal violet staining. 
This method is useful for the rapid detection of highly toxic compounds at 48 h. 
Since the dye stains viable cells, the less intensively coloured cells indicate com-
pound toxicity. Cells were seeded in 1 × 105 cell/well into 0.2 ml growing me-
dium and incubated at 37˚C and 5% CO2 for 24 h. Supernatants were discarded 
and two-fold serial dilutions of each free amphipile were evaluated in triplicate. 
The amphiphile concentrations ranged from 1000 µg/ml to 0.1 µg/ml. Serial di-
lutions were performed for surfactant-containing solutions to achieve the sur-
factant concentrations. Between 1000 µg/ml and 0.5 µg/ml cells were incubated 
for 48 h at 37˚C and 5% CO2. The supernatants from each well were discarded 
and 50 µl/well of crystal violet dye was added and incubated at 37˚C and 5% CO2 
for 30 min. The dye was then removed and the plates were generously washed 
with water. 100 µl/well of acetic acid was added and colour intensity was meas-
ured by spectrophotometer or by a 96-well plate reader capable of measuring 
absorbance at 540 nm. Untreated cells were considered to be the negative con-
trol. The non-toxic limit concentration was calculated as the highest concentra-
tion of compound which produced the same colour intensity than that of the 
negative control. 
3. Results and Discussion 
3.1. Synthesis and Characterization of AG2-Cn 
The monomeric amphipiles AG2-Cn were synthesized with high purity (>95%), 
the mass-average molecular weights are summarized in Table 1. Amphiphiles 
have a net positive charge of +2 at pH 7.4, due to the presence of two residues of 
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ornithine. The RT (retention times) of the different amphiphiles determined by 
RP-HPLC and the experimental molecular mass determined by ESI-MS are also 
shown in Table 1. 
3.2. DNA Binding Assay  
Gel retardation is a technique widely used for assessing complex formation be-
tween plasmid DNA and gene delivery vectors. Amphiphiles condense DNA 
into large particles that remain in the loading well. Figure 2 shows the results of 
agarose gel electrophoresis for the binding affinity for pLenti-CMV-GFP Puro 
plasmid to AG2-Cn. All the compounds tested formed lipoplexes but at different 
N/P ratios. The number of cationic nitrogen of gemini required per phospho-
rous residue of pDNA (i.e., N/P ratio) for complete complexation was found to 
be close to 4.8 and 9.6 for AG2-C12 and AG2-C14, respectively, and 2.4 for 
AG2-C16 and AG2-C18, which is comparable to other cationic amphiphiles with 
excellent gene transfection ability [15]. During gel electrophoresis, fluorescent 
dye bands were present with equal intensity within the N/P ratios 0 - 0.6 for all 
the AG2-Cn, which indicates no prominent binding with pDNA. In contrast, the 
fluorescent dye band disappeared at N/P ratio of 4.8 for AG2-C12, 9.6 for 
AG2-C14, and 2.4 for AG2-C16 and AG2-C18. During the formation of DNA- 
AG2-Cn complexes the migration of DNA is retarded and the fluorescent dye is 
displaced by gemini, which may explain the disappearance of the DNA bands 
[29]. 
 
 
Figure 2. Agarose gel electrophoresis shift assay of AG2-Cn/pLenti-CMV-GFP Puro com- 
plexes at indicated N/P ratios. 
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3.3. Characterization of AG2-Cn/pLenti-CMV-GFP Puro Complexes 
Appropriate size and ζ-potential are important for efficient gene transfection 
[12]. In this study, the particle size and ζ-potential of AG2-Cn/pLenti-CMV-GFP 
Puro complexes were studied by light-scattering technique at different N/P ra-
tios (Table 2 and Table 3). According to Dauty et al. [12], lipoplexes size in-
creases with the increase of N/P ratio or the chain length (C12 to C14) of the am-
phiphile, as it leads to a growth in the particle size (Table 2). The average size is 
reproducible at low charge ratios. However, size values fluctuate considerably 
above N/P ratio of 19.6 due to the onset of precipitation that reduces the accu-
racy of the light scattering measurement. Lipoplex size was reported to have a 
close relationship with transfection efficiency [30]. However, a specific correla-
tion between lipoplex size and transfection efficiency using the AG2-Cn com-
pounds as vectors were not discernible as all the lipoplexes at optimum charge 
ratio showed a similar size (around 110 - 350 nm diameter) and lipoplex sizes 
were variable to N/P ratio, while the compounds showed maximum activity. 
ζ-potentials are negative at low N/P ratio due to excess DNA and become less 
negative as N/P ratio increases to the estimated isoelectric point at N/P ratios 
ranging from 2.4 to 4.8 (Table 3) and remain positive up to an N/P ratio of 28.0. 
The formation of AG2-Cn/pLenti-CMV-GFP Puro complexes appears to occur 
well above the N/P ratio of 1:1 that has been reported for traditional single tail, 
single head surfactants with DNA, or for single head, double tail surfactants with 
DNA [31]. 
 
Table 2. Nanoparticle diameter (nm) of AG2-Cn/pLenti-CMV-GFP Puro complexes as 
measured by dinamic light scattering. 
(N/P)a AG2-C12b AG2-C14b AG2-C16b AG2-C18b 
9.6 146 ± 45 343 ± 175 155 ± 22 107 ± 4 
15 169 ± 15 242 ± 28 215 ± 16 146 ± 32 
19.2 203 ± 81 222 ± 41 195 ± 31 173 ± 47 
28 210 ± 8 331 ± 72 350 ± 128 327± 31 
aRatio of amphiphile amine functions to DNA phosphates. bMean diameter from the multimodal distribu-
tion analysis; average and standard deviation of n = 3 determinations. 
 
Table 3. Zeta-potential (mV) of AG2-Cn/pLenti-CMV-GFP Puro complexes at pH 7.4 as 
measured by dinamic light scattering. 
N/Pa AG2-C12 AG2-C14 AG2-C16 AG2-C18 
1.2 −42 ± 0.833 −40.1 −34.4 ± 0.153 −23.7 ± 0.814 
2.4 −30 ± 2.29 −7.74 ± 3.1 −10.2 ± 0.482 −28 ± 0.751 
4.8 30.1 ± 2.46 33 32.3 ± 2.25 14.9 ± 0.643 
9.6 33.4 ± 5.02 38.5 ± 0.611 38.2 ± 0.351 42.9 ± 0.805 
15 37.8 ± 1.16 38 ± 0.889 37.9 ± 0.513 39.3 ± 2.43 
19.2 37.9 ± 0.551 37.4 ± 0.265 37.5 ± 0.416 37.8 ± 1.79 
28 35.2 ± 1.82 34.4 ± 0.569 34.8 ± 0.493 37.1 ± 0.2 
aRatio of amphiphile amine functions to DNA phosphates. 
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The ζ-potential of the lipoplexes might be considered to be a good indicator of 
the importance of the first step in the overall transfection process, which is the 
adhesion of the lipoplex to the negatively charged cell membrane. Nevertheless, 
as it has been previously shown [25], a higher positive ζ-potential does not ap-
pear to correlate to higher transfection efficiency, since although lipoplexes ac-
quire a positive charge between +33 and +38 up to an N/P ratio of 4.8, the 
minimum and a maximum activity are observed at N/P ratios of 15.0 and 28.0, 
respectively. 
3.4. Critical Micellar Concentrations 
Knowledge on CMC is of upmost importance for transfection: the presence of 
excess cationic micelles of the amphiphiles during the complex formation step 
may trigger the aggregation of anionic condensed DNA particles; a high CMC is 
thus preferable. Onthe other hand, once oxidized, the resulting dimeric amphi-
phile (gemini) should have a very low CMC to avoid early extraction from the 
amphiphile/DNA complexes during the gene delivery process [32] [33]. The 
CMCs of the monomeric amphiphiles were determined at neutral pH in 10 mM 
DTT using a Du Nouytensiometer. The results are presented in Table 1. In this 
paper, we assume that the differences observed for the CMCs of the synthesized 
compounds are due only to the different hydrophobic chains formed. Similarly 
to the trend exhibited by conventional amphiphiles, the CMC of AG2-Cn de-
creased as alkyl chain length increased from C12 to C14 or from C12 to C18. We at-
tribute the unexpected value for C16 to the presence of AG2 pentapentide not 
hydrophobised, because the quality of palmitic acid used was not optimal, com-
pared to the other fatty acids employed. Finally, AG2-C14 and AG2-C18 were the 
molecules that showed the lowest CMC value, with a surface tension at concen-
tration higher than the rest, conditions which allow the efficient formation of 
lipoplexes. 
3.5. Gene Transfection Efficiency 
Gene transfection efficiency in HEK293 T and CHO-K1 cells was evaluated by 
expression assays, using GFP as the reporter gen. PEI and Lipofectamine 2000 
were used as controls. It was determined that all the compounds tested were ac-
tive for both cell lines tested, significantly higher against CHO-K1 cells, except 
AG2-C12. In particular, AG2-C18 was able to transfect 30% - 40% more CHO-K1 
cells. In comparison, AG2-C18 transfected 67% CHO-K1 cells, obtaining a value 
similar to the one obtained for PEI (67%) and greater than the one obtained for 
Lipofectamine 2000 (55%). It seemed that gene transfection efficiency was de-
pendent on N/P ratio, which could be observed for both HEK293 T and CHO- 
K1 cells (Figure 3(a) and Figure 3(b)). Except for the least active amphiphile, 
AG2-C16, all compounds showed two peaks of activity at N/P ratio of 15 and 28, 
respectively. Normally, most compounds of this type have a rising activity curve 
with a single maximum [11] [28] [34]. Although the reasons are not clear yet, we 
can assume that the low activity observed for all compounds atan N/P ratio of 15  
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Figure 3. In vitro transfection efficacy of AG2-Cn/pLenti-CMV-GFP Puro complexes. 
Notes: Quantitative measurement of transfection efficiency forAG2-Cn/pLenti-CMV-GFP 
Puro complexes at diferent N/P ratios in CHO-K1 cells (a) and HEK293 T17 cells (b) us-
ing flow citometry. Fluorescent images of transfection efficiency for AG2-Cn/pLenti- 
CMV-GFP Puro complexes at diferent N/P ratios in CHO-K1 cells (c). 
 
can be because lipoplexesare still not fully formed. As measured by DLS sizes are 
smaller (average 192 nm) than those observed at an N/P ratio of 28 (average 305 
nm) (Table 2). The fluorescence intensity of AG2-C18/pLenti-CMV-GFP Puro 
complexes at N/P ratio of 28 was comparable to that of PEI/ pLenti-CMV-GFP 
Puro and Lipofectamine 2000/pLenti-CMV-GFP Puro complexes (Figure 3(c)). 
Given that for all amphiphiles the peptide sequence (polar head) is the same, we 
can attribute the increased activity for AG2-C18 to the presence in the molecule 
of the hydrophobic tail of 18 carbon unsaturated oleic acid. This agrees with 
Fielden et al. [11] and Castro et al. [35], who reported that the introduction of 
unsaturation to C18 tails (85% cis) transfects CHO-K1 cells with efficiency com-
parable to Lipofectamine Plus/2000. 
The amphiphiles designed for this paper are based on the amino acid se-
quence of a gemini compound tested by our group as antimicrobials [22] [23]. 
These gemini were designed considering the structural requirements reported 
for antimicrobial peptides (AMPs) and cell penetrating peptides (CPPs) regard-
ing the need for positive charges (basic peptides: Lys, Arg, Orn) and the presence 
of hydrophobic residues (Trp, Tyr, Phe) involved in the membrane destabiliza-
tion processes [21] [36] [37]. The original sequence of these antimicrobials am-
phiphiles was modified by the addition of the cysteine residue in order to be 
tested as DNA transfection agents. The thiol group of cysteine from AG2-Cn 
undergoes oxidative coupling to yield cystine and produces gemini in presence 
of DNA. These gemini surfactants self-assembled at a much lower concentration 
than their monomeric counterparts and they also showed a lower surface tension 
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at the CMC. This improvement in the interfacial properties makes them less 
suitable to act individually at cell membrane level, and more suitable to cross 
without damaging it. The residues of ornithine are positively charged at neutral 
pH, which helps particles to interact with plasmid DNA and cellular membrane. 
Ornithine also helps overcome one of the biological barriers associated with the 
process of lipofection, which is DNA escape from the endosome (to avoid the 
formation of lysosomes and the destruction of plasmid by nucleases). Mean-
while, the interaction of tryptophane residues with GAG (glycosaminoglycan) 
cell membranes promote the endocytosis of DNA [38] [39]. The design of these 
amphiphiles is new. The literature describes the importance of the coexistence of 
tryptophane and cysteine in the sequence of some CPP for cellular internaliza-
tion [40], but there are no reports on amphiphilic amino acid derivatives which 
combine tryptophan, cysteine, and ornithine residues in the same structure. We 
believe that this combination could be the explanation for the fact that the lipo-
plexes formed from these amphiphiles are much more easily internalized in 
CHO-K1 cells than in other cell lines, which should be further researched. 
3.6. Hemolytic Activity Study  
The membrane disruption of AG2-Cn was evaluated by hemolytic assay. Figure 
4(a) shows the hemolysis of the free amphiphiles in a concentration range from 
1000 µg/mL to 0.5 µg/mL. All amphiphiles showed concentration-dependent 
hemolysis at Ph 7.4. However, the hemolytic activity observed is markedly lower 
than the activity observed for similar molecules [40]. In fact, for a concentration 
of about 6 µM Xu et al. [41] detected between 10% and 60% hemolysis while, at 
the same concentration, our amphiphiles reached between 7% and 20% hemoly-
sis. The AG2-Cn/pLenti-CMV-GFP Puro complexes also show concentration- 
dependent hemolytic activity (Figure 4(b)). However, except for AG2-C16, for 
the entire range of concentrations tested, hemolytic activity decreases signifi-
cantly when amphiphileis as part of the complex. Only 15% hemolysisis ob-
served when the concentration of amphiphile corresponds to the maximum ac-
tivity (N/P of 28, approximately 20.5 μg/mL). 
 
 
(a)                                   (b) 
Figure 4. Hemolytic activities of AG2-Cn (Free carriers) (a) and AG2-Cn/pLenti-CMV- 
GFP Puro complexes (b) at variable concentrations at pH 7.4. TritonX-100 (1%, w/v), 
PBS and its complexes with pLKV1-EGFP plasmid were used as controls with 100% and 
<10% of hemolytic activity respectively. 
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3.7. Cytotoxicity Assay 
The cytotoxicity for AG2-Cn in CHO-K1 cells is shown in Figure 5. As it can be 
seen, all the amphiphilic amino acid derivatives showed low cytotoxicity. No cy-
totoxicity was observed over the 24-h period for AG2-C12 and AG2-C16 at 0.48 - 
62.5 μg/mL concentrations and for AG2-C14 and AG2-C18 at 0.48 - 32.25 µg/mL 
concentrations, which indicates favourable biocompatibility with CHO-K1 cells. 
The concentrations at which maximum activity can be observed for these com-
pounds (N/P ratio 28) are within those ranges The low cytotoxicity observed is 
consistent with the lack of antimicrobial activity observed for these compounds. 
In fact, all compounds were tested in their activity towards pathogenic bacteria 
at two concentrations, one below and one above CMC. Activity was observed 
only for AG2-C12, which was poorly active against Bacillus subtilis. 
4. Conclusion 
Four biocompatible and dimerizable amphiphilic aminoacid-based derivatives 
were designed and synthesized for delivering nucleic acids. The carriers had low 
critical micelle concentrations and formed nanoparticles with plasmid DNA. 
The nucleic acid nanoparticles with all the carriers showed low cytotoxicity and 
high activity at physiological pH. The amphiphilic carriers were more effective 
to transfect CHO-K1 cell, mainly AG2-C18, with efficiency 12% higher than that 
of Lipofectamine 2000. Further studies on a greater number of cell lines are re-
quired to establish specificity of action, to correlate the physicochemical and 
structural properties for AG2-Cn/pLenti-CMV-GFP Puro complexes with in vi-
tro transfection of CHO-K1 cells, and to contribute to a better understanding of 
the gene delivery process.  
 
 
Figure 5. Cytotoxicity of AG2-Cn on CHO-K1 cells. Data are shown as the mean ± stan-
dard deviation (n = 3). 
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